6-Iodo-3-isopropyl-[1,2,4]triazolo[4,3-b]pyridazine → HCID 57929864, compound
Reaction equation
I[C:2]1[CH:3]=[CH:4][C:5]2[N:6]([C:8]([CH:11]([CH3:13])[CH3:12])=[N:9][N:10]=2)[N:7]=1.[F:14][C:15]1[CH:20]=[C:19]([F:21])[CH:18]=[CH:17][C:16]=1[C:22]1[C:26](I)=[C:25]([CH3:28])[O:24][N:23]=1>>[F:14][C:15]1[CH:20]=[C:19]([F:21])[CH:18]=[CH:17][C:16]=1[C:22]1[C:26]([C:2]2[CH:3]=[CH:4][C:5]3[N:6]([C:8]([CH:11]([CH3:13])[CH3:12])=[N:9][N:10]=3)[N:7]=2)=[C:25]([CH3:28])[O:24][N:23]=1Participants
3
Procedure
6-Iodo-3-isopropyl-[1,2,4]triazolo[4,3-b]pyridazine (0.400 g, 1.25 mmol, Preparation #H.1) and 3-(2,4-difluorophenyl)-4-iodo-5-methylisoxazole (0.360 g, 1.25 mmol) were coupled using General Procedure I.1 to provide the title compound (0.098 g, 22%): LC/MS (Table 1, Method g) Rt=2.16 min; MS m/z: 356.0 (M+H)+.
Sources & evidence
- ORD record
- ord-123cb68a344942b7b6597c8772d884da
- Source dataset
- uspto-grants-2012_05
- Patent number
- US08188083B2
Reaction notes
Loading…